IMTP.PA
Latest Trade
41.26EURChange
-0.36(-0.86%)Volume
29,033Today's Range
-
41.4852 Week Range
-
51.65As of on the Euronext Paris ∙ Minimum 15 minute delay
Previous Close | 41.62 |
|---|---|
Open | 41.48 |
Volume | 29,033 |
3M AVG Volume | 5.69 |
Today's High | 41.48 |
Today's Low | 40.86 |
52 Week High | 51.65 |
52 Week Low | 32.10 |
Shares Out (MIL) | 79.25 |
Market Cap (MIL) | 3,308.20 |
Forward P/E | 11.79 |
Dividend (Yield %) | 4.99 |
Imerys Expands In Refractories Solutions In India
Imerys Expands In High Performance Abrasives In China
Imerys Appoints Alessandro Dazza As CEO
Imerys SA is a France-based specialty minerals company that provides a range of customizable solutions to many industries, such as construction materials, mobile energy, steelmaking, agri-food, automotive and cosmetics. The Company operates through two segments: Performance Minerals and High Temperature Materials and Solutions. Performance Minerals provides additives for paints and coatings, components for technical and conventional ceramics, additives for plastics and polymers, fillers and coatings for printing and writing paper, as well as board and packaging, filtration agents for liquid foodstuffs and blood plasma, specialty graphite for mobile energy and precision. High Temperature Materials and Solutions offers refractory minerals and solutions for high-temperature industrial processes, bentonite for foundry molds, corundum powders for abrasives and high-performance binders for floor screeds. The Company is active globally.
Industry
Construction - Raw Materials
Executive Leadership
Patrick Kron
Chairman of the Board, Interim Chief Executive Officer
Paul Desmarais
Vice Chairman of the Board
Olivier Pirotte
Chief Financial Officer, Member of the Executive Committee
Vincent Lecerf
Chief Human Resources Officer, Member of the Executive Committee
Philippe Bourg
Senior Vice President Refractory Abrasives & Construction, Member of the Executive Committee
Price To Earnings (TTM) | -- |
|---|---|
Price To Sales (TTM) | 0.73 |
Price To Book (MRQ) | 1.06 |
Price To Cash Flow (TTM) | 219.09 |
Total Debt To Equity (MRQ) | 77.91 |
LT Debt To Equity (MRQ) | 67.77 |
Return on Investment (TTM) | -5.03 |
Return on Equity (TTM) | -3.94 |
French group Imerys SA <IMTP.PA> is exploring options for its North America talc unit, which filed for bankruptcy after being drawn into cancer lawsuits connected to Johnson & Johnson's <JNJ.N> baby powder, Bloomberg reported on Wednesday, citing people with knowledge of...
French group Imerys SA is exploring options for its North America talc unit, which filed for bankruptcy after being drawn into cancer lawsuits connected to Johnson & Johnson's baby powder, Bloomberg reported on Wednesday, citing people with knowledge of the matter.
French specialty minerals company Imerys <IMTP.PA> on Tuesday cut its outlook for 2019 and announced the resignation of Chief Executive Officer Conrad Keijzer.
The Missouri Supreme Court on Thursday halted an upcoming trial in a case brought by women who claim talc supplied by Imerys Talc America for use in Johnson & Johnson products gave them cancer, saying it wanted to consider a jurisdictional challenge by Imerys.
The following are mergers under review by the European Commission and a brief guide to the EU merger process:
The following are mergers under review by the European Commission and a brief guide to the EU merger process:
French roofing business Imerys has set final terms on a €580m (£516.6 million) leveraged loan with a heavy discount on a newly introduced €100m second-lien loan.
A unit of French minerals company Imerys SA settled claims by 22 women related to talc supplied to Johnson & Johnson for making baby powder for at least $5 million, Bloomberg reported on Friday, citing people familiar with the matter.
The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:
France's Imerys is selling its roof tiles business as it streamlines its portfolio, people close to the matter said, expecting the asset to be valued at around 1 billion euros (£0.9 billion), with private equity most likely to clinch the deal.
Johnson & Johnson and Imerys Talc America, a unit of Imerys SA, must pay $117 million in damages in a case involving a man who said he developed cancer due to his exposure to asbestos in talc-based products, a New Jersey state court jury said on Wednesday.
Johnson & Johnson and an Imerys SA unit must pay an additional $80 million in punitive damages in a lawsuit claiming a man developed cancer due to his exposure to asbestos in talc-based products, a New Jersey state court jury said on Wednesday.
AURELIUS EQUITY OPPORTUNITIES SE & CO KGAA:
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.